Work

Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis

Year: 2007

Type: article

Source: Kidney International

DOI: 10.1038/sj.ki.5002717

Authors: M. Petersen, M. Thorikay, M. Deckers, M. van Dinther, E.T. Grygielko, F. Gellibert, A.C. de Gouville, S. Huet, P. ten Dijke, N.J. Laping

Institutions: Leiden University Medical Center, GlaxoSmithKline (France), GlaxoSmithKline (United States)

Language: English

Topic: Chronic Kidney Disease and Diabetes

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: European Commission

OpenAlex ID: W1996046117

FWCI: 8.351

Cites: 48

Cited by: 221

Related to: 10